Skip to content
PubMed This is a summary of 37 peer-reviewed journal articles Updated
Nephrology

Collagen Type III Glomerulopathy: A Patient Guide

At a Glance

Collagen type III glomerulopathy is a rare kidney disease in which type III collagen builds up in the kidney’s filters. Electron microscopy confirms the diagnosis, while care focuses on blood pressure, reducing protein in urine, and monitoring kidney function.

Note: This guide is for informational purposes and does not replace individualized medical advice.

Collagen type III glomerulopathy, also known as collagenofibrotic glomerulopathy, is a highly unusual kidney disease characterized by the abnormal buildup of type III collagen within the kidney’s filtering units, the glomeruli. While this type of collagen is common in other parts of the human body, it is not typically found in the healthy filters of the kidney. When it begins to accumulate there, it disrupts the kidney’s delicate architecture, leading to a loss of protein into the urine and a gradual decline in the organ’s ability to filter waste from the blood [1][2].

This condition is extremely rare, with only about 100 published cases reported in the medical literature worldwide. (Because this is an approximate literature count, the true number of affected people is unknown, but it illustrates how uncommon the condition is). Because it is so uncommon, it is often a “hidden” disease that can be difficult to identify. On standard medical tests and basic microscope views, it frequently mimics more common conditions like diabetic kidney disease or certain immune-related inflammations. For this reason, a definitive diagnosis requires electron microscopy—a high-powered specialized microscope—to see the unique, curved collagen fibers that are the “signature” of this disease [3][4].

Unlike many other kidney disorders, primary collagen type III glomerulopathy is generally a non-immune-complex mediated disease. This means the primary driver of the collagen deposition is not typically your immune system attacking your kidneys, although secondary forms and coexisting immune diseases are reported, and a negative immune test does not absolutely guarantee no systemic process is present. Because the immune system is generally not the primary driver of the collagen buildup itself, standard treatments like steroids or other immune-suppressing drugs are usually not effective for the collagen deposition and can even cause unnecessary harm. Instead, management focuses on supportive care, which involves using specific medications to lower the pressure inside the kidneys and control blood pressure to protect the remaining healthy tissue [5][6].

The journey with this diagnosis is different for everyone. While some people may experience a steady decline in kidney function over several years, others remain stable for long periods with careful monitoring and management. Because there is no specific cure, your care will focus on protecting your kidney health through lifestyle and blood pressure control. Understanding that you are dealing with a rare structural condition rather than an active immune attack can help you and your medical team focus on the most effective ways to preserve your long-term health [1][7].

Common questions in this guide

What is collagen type III glomerulopathy?
Collagen type III glomerulopathy is a very rare kidney disease in which type III collagen builds up in the glomeruli, the kidney’s filtering units. This buildup can cause protein to leak into the urine and may gradually reduce kidney filtering function.
How do doctors confirm collagen type III glomerulopathy?
Doctors usually need a kidney biopsy examined with electron microscopy to confirm this condition. The specialized test can show distinctive curved or banded collagen fibers and help distinguish the disease from more common kidney conditions that look similar on routine testing.
Do steroids treat collagen type III glomerulopathy?
In primary collagen type III glomerulopathy, steroids and other immune-suppressing medicines usually do not remove the abnormal collagen because an immune attack is not usually the main driver. They can cause avoidable side effects when used without a clear reason, although doctors may evaluate for a coexisting immune disease.
What treatment can help protect my kidneys?
Care usually focuses on supportive treatment rather than a specific cure. ACE inhibitors or angiotensin receptor blockers may reduce pressure in the kidney filters, lower protein in the urine, and help control blood pressure, along with lifestyle measures and regular monitoring.
What is the outlook for people with this condition?
The course varies from person to person. Some people have a gradual decline in kidney function over several years, while others remain stable for long periods with monitoring and care.
Should I see a specialist for this rare kidney disease?
Because the condition is uncommon, ask whether your care can be coordinated with a nephrologist who has experience with rare glomerular diseases. A specialist can also help review biopsy findings and plan long-term monitoring.

Get notified when new evidence is published on Collagen type III glomerulopathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (7)
  1. 1

    Four cases of type III collagen deposition glomerulopathy and summary of the literature.

    Lin X, Xu Y, Lin X, et al.

    International urology and nephrology 2026; doi:10.1007/s11255-026-05431-7.

    PMID: 42859380
  2. 2

    Collagenofibrotic glomerulopathy.

    Kurien AA, Larsen CP, Cossey LN

    Clinical kidney journal 2015; (8(5)):543-7 doi:10.1093/ckj/sfv061.

    PMID: 26413279
  3. 3

    Type III Collagen Glomerulopathy Presenting With Divergent Histopathological Patterns: Report of Two Adult Cases and Diagnostic Pitfalls.

    Nili F, Abdollahi A, Arabmohammadi P, Salarvand S

    Case reports in nephrology 2026; (2026()):6022775 doi:10.1155/crin/6022775.

    PMID: 42775177
  4. 4

    Collagenofibrotic glomerulopathy in a kidney transplant recipient: A first report.

    Jdiaa SS, Moeckel GW, Kfoury HM, et al.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2021; (21(5)):1948-1952 doi:10.1111/ajt.16399.

    PMID: 33206467
  5. 5

    Collagen type III glomerulopathy: A case report and review of 20 cases.

    Dong J, Wei H, Han M, et al.

    Experimental and therapeutic medicine 2015; (10(4)):1445-1449 doi:10.3892/etm.2015.2695.

    PMID: 26622504
  6. 6

    Telmisartan alleviates collagen type III glomerulopathy: A case report with literature review.

    Guo Q, Liu L, Nie P, Luo P

    Experimental and therapeutic medicine 2020; (20(6)):140 doi:10.3892/etm.2020.9269.

    PMID: 33093878
  7. 7

    Collagen type III glomerulopathy: 
case report and review of the literature
.

    Chen X, Wang H, Xu W, Zhu J

    Clinical nephrology 2017; (87 (2017)(1)):39-46 doi:10.5414/CN108907.

    PMID: 27900943

This guide explains collagen type III glomerulopathy for education and does not replace individualized medical advice. Ask a nephrologist and your care team to interpret your biopsy, test results, and treatment plan.